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In situ immune response in human dermatophytosis: 
possible role of Langerhans cells (CD1a+) as a risk factor for 
dermatophyte infection
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ABSTRACT
Dermatophytosis is a cutaneous mycosis caused by a plethora of keratinophilic fungi, 
but Trichophyton rubrum is the most common etiological agent. Despite its high prevalence 
worldwide, little is known about the host defense mechanisms in this infection, particularly 
the in situ immune response. Using an immunohistochemistry approach, we investigated the 
density of CD1a+, factor XIIIa+ and CD68+ cells in the skin of dermatophytosis patients. 
Langerhans cells (CD1a+ cells) were significantly decreased in the epidermis of patients, 
both in affected and unaffected areas. In the dermis, however, no differences in the density 
of macrophages (CD68+ cells) and dermal dendrocytes (factor XIIIa+ cells) were observed. 
These results suggest that the decreased number of Langerhans cells may be a risk factor for 
development of dermatophytosis.
KEYWORDS: Dermatophytosis. Innate immune response. Langerhans cells. Macrophages. 
CD68+. Factor XIIIa+. CD1a+. Trichophyton rubrum.
INTRODUCTION
Dermatophytosis is a superficial fungal infection with an outstanding morbidity 
rate in humans, affecting approximately 20% of the world population. More than 30 
species of fungi, belonging to three main genera (Epidermophyton, Microsporum and 
Trichophyton), have been identified as causative agents1,2, but Trichophyton rubrum 
is the most frequent species in the human context, able to suppress and evade the 
host immune response, establishing infections refractory to current therapeutics3,4.
These fungi are characterized by invading the stratum corneum and other 
keratinized tissues like nail and hair, where they thrive by secreting enzymes and 
degrading keratin to obtain nutrients, also promoting tissue damage. Thus, clinical 
presentation is variable and relies on several factors as (i) the site of infection, 
(ii) the immunological response of the host, and (iii) the fungal species involved.
Overall, patients with acute superficial dermatophytosis mount cell-mediated 
immune responses against the causative agent, which is associated to resolution of 
the infection5,6-9. In contrast, those who suffer from chronic or recurrent infections 
are unable to develop this response10, but the reasons for this inability are not yet 
known. Recently, several reports described severe and occasionally life-threatening 
invasive disease (deep dermatophytosis) associated to genetic mutations in the 
innate immunity-associated molecule CARD96,8,11, highlighting the need to better 
understand the immune response in this infection. Recently, studies in animal 
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models of dermatophytosis have demonstrated that Th17 
and eventually Th1 immune responses were essential to the 
optimal control of this fungal infection12,13.
Immune cells like dendritic cells (DCs), macrophages, 
CD4+ and CD8+ T cells and natural killer (NK) cells, as 
well as some cytokines (i.e. interleukin [IL]-17, IL-1β, and 
interferon [IFN]-γ) have been reported to mediate protection 
against different fungi in murine and human experimental 
systems10,14. Particularly in the skin, macrophagesplay 
critical roles in initiation, maintenance and resolution of 
inflammation15, and DCs, the major antigen-presenting cells 
(APC), can clearly influence the development of cellular 
immunity to dermatophytes16.
Langerhans cells (LCs) are a population of DCs whose 
main function is antigen sampling and presentation in the 
epidermis17. In the dermis, an equivalent DC population, 
called dermal dendrocytes (DD), are as potent as LCs 
in antigen presentation and they have been involved 
in the pathogenesis of different fungal infections as 
paracoccidioidomycosis and chromoblastomycosis18,19. 
Curiously, LCs recognize the antigen trichophytin20 and 
altered LC proliferation was associated to dermatophytosis21, 
hinting a possible role in this infection.
Considering the paucity of data about the host defense 
mechanisms in dermatophytosis, particularly in situ 
observations, the main objective of this study was the 
immunohistochemical analysis of LCs, DDs and CD68+ 
macrophages in skin lesions of dermatophytosis patients.
MATERIALS AND METHODS
Patients 
Ten patients with dermatophytosis (involving at least 
three distinct body parts) were recruited at the Mycology 
Outpatient Clinic, Division of Clinical Dermatology, from 
the Hospital das Clinicas of the University of Sao Paulo. 
Skin samples from 10 healthy individuals undergoing 
plastic surgery were included as controls. Inclusion criteria 
were: (i) patients without any comorbidity affecting the 
immune response or predisposing to dermatophytosis 
(e.g., primary or secondary immunosuppression, diabetes 
mellitus, Cushing’s disease, transplant recipients); 
(ii) subjects who had not used topical or systemic 
treatments one month prior to sample collection; (iii) 
isolation and identification of T. rubrum from skin lesions, 
performed by microscopic examination of lesion samples 
and culture in Agar Sabouraud (Becton, Dickinson and 
Company, Heidelberg, Germany) for fungal isolation. 
Patients who were under 18 years of age or pregnant 
were excluded.
The study was approved by the Ethics Committee of 
the Hospital das Clinicas of the University of Sao Paulo 
(Approval Nº 673/06) and all participants provided written 
informed consent prior to sample acquisition.
Immunohistochemistry analysis
One sample per patient, from the border of the active 
lesion, was taken with a standard dermatological biopsy 
puncher (5 mm). In the control group, skin samples were 
obtained from cosmetic surgery. 
A streptavidin-biotin peroxidase method was used, 
as previously described22. Briefly, after deparaffinization 
and hydration, antigen recovery was performed in hot 
citrate bath (10 mm/pH 6.0) for 40 min. Blockade of 
endogenous tissue peroxidase with 3% hydrogen peroxide 
solution was performed and samples were incubated 
overnight at 4 °C with the following primary antibodies: 
monoclonal mouse anti-human CD68 (clone KP1; Dako 
Corporation, Carpinteria, CA, USA); anti-CD1a (clone 
010; Dako Corporation) or anti-factor XIIIa (clone 
E980; CM 357; Biocare Medical, Concord, CA, USA). 
Amplification and visualization of the reactions were 
performed with Novolink™ Max polymer detection systems 
(RE7260-K; Novocastra). Reactions were developed using a 
diaminobenzidine chromogen solution (DAB; Novocastra) 
and counterstained with Harris hematoxylin. All reactions 
were performed with positive and negative controls, the 
latter consisted in the omission of the primary antibody. 
Quantitative analysis of immunostained cells 
Immunostained cell counting was performed in an 
AxionVision microscope (Carl Zeiss, San Diego, CA, USA) 
coupled with Pentium IV and AxioShop 2 Plus software.
Cells were quantified in 10 fields featuring histological 
sections at 400 × magnification and those stained in brown 
were considered immunoreactive.
Statistical analysis 
The number of positive cells in the three groups was 
compared using Kruskal Wallis and Dunn’s post-test with 
the level of significance set at 95 %. The Graph Pad Prism 
software, version 5.0 for Windows (Graph Pad software, 
San Diego, CA, USA) was used.
RESULTS
Our group of patients was composed of seven male 
(70%) and three female (30%) subjects, whose mean age 
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was 38 years old (range 21-57). The patients presented 
either involvement of two (70% of the cases) or one 
body segment (30%). The anatomical sites affected were 
abdomen, buttocks, arms and thighs. The lesions were in 
general typical, circular or oval, and erythematous, often 
with scaling on the lesions, with more intense signals of 
inflammation within the limits of the lesions. Time of onset 
of the lesions ranged from 5 months to 2 years.
In the control group, six were male and four were 
female, their mean age was 34 years (range 28-52). 
All samples from dermatophytosis patients were positive 
for T. rubrum. Histopathology analysis indicated perivascular 
lymphohistiocytic infiltration in the upper dermis and 
absence of neutrophils in the lesions (data not shown), albeit 
some authors described the presence of neutrophils in the 
stratum corneum, compact orthokeratosisand presence of 
hyphae in dermatophytic lesions23. 
LCs are normally present in the epidermis and can 
be identified by the phenotypic marker CD1a24. Albeit 
hematoxilin staining did not reveal any inflammatory 
infiltrate in the epidermis of patients (data not shown), the 
density of CD1a+ cells was significantly reduced in both, the 
area of affected (90.7 ± 64.3 cells/mm2, mean±s.d.) skin as 
well as the unaffected skin (77.9 ± 66.5 cells/mm2, mean±s.d.) 
compared to the control group (158.5 ± 99.2 cells/mm2, 
mean±s.d.) (Figure 1A and Figure 2A).
For DDs, characterized by expression of Factor 
XIIIa25,  no statistically significant differences 
were observed in their frequency between affected 
(90 .67  ±   64 .32  ce l l s /mm 2,  mean±s .d . )  and 
unaffected skin dermis (76.30 ± 62.86 cells/mm2, 
mean±s.d.) or when compared to the control group (118.9 ± 
49.93 cells/mm2, mean±s.d.) (Figure 1B and Figure 2B). 
Finally, regarding dermal macrophages, the density 
of CD68+ cells in both groups (affected: 35.36 ± 27.64, 
unaffected: 50.18 ± 35.33 cells/mm2) was also not 
statistically different and was similar to the one observed in 
the control group (38.91±26.85) (Figure 1C and Figure 2C).
Figure 1 - Cell density of immunological markers at the lesion sites of patients with dermatophytosis. Dermatophytosis patients’ 
skin samples (lesion areas and unaffected skin) and healthy controls skin samples were immunostained for the following cell 
populations: A) CD1a+ cells; B) Factor XIIIa+ cells; C) CD68+ cells. Data are expressed as median ± interquartile range of the density 
of immunostained cells. Statistical comparisons were performed with Kruskal Wallis and Dunn’s post-test with a confidence level 
of 95%. n = 10; *p<0.05.
Figure 2 - Immunohistochemistry pattern of CD1a, Factor XIIIA and CD68. Cells density of CD1+ cells (red arrow) in lesion areas 
(A) and in a healthy control skin (B) Cell density of factor XIIIa+ cells in lesion areas (C) and in a healthy control skin (D) CD68+ 
cells in lesions areas skin (E) in a healthy control skin. Magnification: x 200.
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DISCUSSION
Dermatophytosis is a benign fungal infection that 
affects keratinized tissues, but, depending on the host 
immune status, it may progress to deep-seated infections, 
resulting in serious complications as severe forms include 
disseminated and/or invasive dermatophytosis, i.e., deep 
dermatophytosis and trichophytic granuloma (Majocchi’s 
granuloma)26,27. Due to the lack of studies exploring 
host-pathogen crosstalk in situ, immunopathological 
analyses may contribute to the understanding of the 
disease pathogenesis and the mechanisms associated to its 
different clinical presentations. In this study, we evaluated 
the histopathological changes in dermatophytosis lesions 
and the tissue distribution of DCs and macrophages, key 
cells in the host defense.
Our study showed a predominance of male patients 
(70%) in agreement with previous studies1,28,29. The 
unequal incidence between both sexes can be explained 
by differences in occupational exposure28. Even though 
all ages are susceptible to chronic dermatophytosis, most 
of our patients (70%) are between 30 – 50 years old, an 
age interval coincident to individuals in the labor phase28. 
Considering the essential role of APCs in determining 
the course of some infectious diseases, we evaluated these 
populations in our skin samples and detected a lower density 
of CD1a+ cells in dermatophytosis patients, raising the 
possibility that T. rubrum infection would be responsible for 
the decreased expression of this marker. We can postulate 
two potential, non-mutually exclusive, mechanisms for this 
observed decreased expression of CD1a: (i) downregulation 
of CD1a expression or (ii) decrease in the residing 
population of skin APCs due to their migration to regional 
lymph nodes for antigen presentation. Regarding the first 
possibility, it has been described that T. rubrum releases 
a variety of molecules, including proteases30-32, that 
can interact with host cells and eventually lead to down 
regulation of the expression of surface markers such as 
CD1a in LCs, thereby interfering with their function. In our 
second hypothesis, activated skin APCs migrate to regional 
lymph nodes to induce adaptive immune responses, but the 
systemic cellular immune response of dermatophytosis 
patients shows a tendency towards a non-protective, 
pathology-inducing, Th-213,33,34 response, even though their 
LCs are able to produce pro-inflammatory mediators, IL-12 
included, locally35. Thus, we hypothesize that T. rubrum 
(or its products)-mediated activation and migration of LCs 
from the epidermis would not necessarily result in better 
in situ protective responses.
Curiously, we have also observed a reduced expression 
of CD1a in the healthy/unaffected skin of dermatophytosis 
patients. Some authors showed a strong expression of CD1 
proteins (CD1a, -b and -c) in patients with tuberculoid 
(benign) form of leprosy, while poor CD1a expression 
would be linked to the failure in pathogen restriction, 
characteristic of the lepromatous pole36. In cutaneous 
leishmaniasis, Jabbour et al. (2015) have also observed a 
decrease in CD1a expression and they postulated this could 
occur through two non-excluding mechanisms: either via 
direct CD1a receptor uptake by Leishmania amastigotes or 
through a negative feedback inhibition of CD1a by double 
negative CD3 T-regulatory cells15. It is tempting to speculate 
that a decreased number of LCs may be a risk factor for the 
development of dermatophytosis and future studies should 
consider analyses of the healthy skin in dermatophytosis 
patients.
For DDs and macrophages, no association between 
cellular density and dermatophytosis status was found. Sotto 
et al.18 showed increased numbers of factor XIIIa+ cells in 
patients with American cutaneous leishmaniasis. DDs can 
internalize Leishmania amastigotes, thus participating in 
the pathogenic mechanisms by acting as APCs. T. rubrum, 
however, rarely reach the dermis and in none of our cases 
we could find hyphae or arthroconidia in this layer even 
by using a specific mycological staining (Grocott stain) 
(data not shown). Therefore, we speculate that the lack of 
alterations in the frequency of these two cell types could 
be explained by the lack of infection-driven inflammation 
in this compartment. 
Albeit the inherent limitations of the IHC technique, 
and the restricted number of patients and surface markers 
employed, in summary, we showed here that T. rubrum 
infection is predominantly localized in the epidermis, 
where decreased numbers of LCs would result in defective 
antigen presentation; pointing to a possible mechanism for 
the chronicity or recurrence of this mycosis. Further studies 
should consider whether antifungal treatment would alter 
these observed abnormalities and if they are associated with 
active disease only. 
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